Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 214.80B | 212.34B | 196.62B | 184.03B | 170.32B | 163.64B |
Gross Profit | 47.07B | 44.89B | 35.86B | 29.68B | 30.64B | 31.30B |
EBITDA | 27.96B | 27.01B | 22.70B | 15.62B | 17.64B | 19.80B |
Net Income | 12.88B | 12.20B | 10.28B | 6.87B | 6.12B | 8.38B |
Balance Sheet | ||||||
Total Assets | 209.27B | 209.82B | 192.68B | 180.00B | 164.65B | 159.37B |
Cash, Cash Equivalents and Short-Term Investments | 32.65B | 34.39B | 22.81B | 22.03B | 25.86B | 21.69B |
Total Debt | 7.60B | 9.74B | 6.78B | 11.96B | 12.03B | 11.83B |
Total Liabilities | 65.64B | 64.55B | 60.54B | 59.43B | 55.15B | 56.29B |
Stockholders Equity | 143.63B | 145.27B | 132.14B | 120.57B | 109.49B | 103.08B |
Cash Flow | ||||||
Free Cash Flow | 16.43B | 14.69B | 13.63B | -3.36B | 2.84B | 12.09B |
Operating Cash Flow | 24.86B | 21.34B | 19.93B | 8.27B | 14.02B | 18.85B |
Investing Cash Flow | -11.98B | -12.46B | -10.57B | -11.01B | -7.80B | -6.58B |
Financing Cash Flow | -5.67B | -3.42B | -4.34B | -5.79B | -4.83B | -2.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥27.92B | 9.12 | 5.68% | 4.06% | -0.35% | -14.20% | |
80 Outperform | ¥70.79B | 11.82 | 8.48% | 7.09% | 2.79% | -10.78% | |
78 Outperform | ¥163.71B | 12.52 | 9.33% | 2.27% | 6.29% | 13.43% | |
78 Outperform | ¥59.53B | 10.24 | 5.01% | 4.01% | 3.38% | -15.37% | |
76 Outperform | ¥81.00B | 3.00 | 7.10% | 12.25% | 6.19% | 32.01% | |
75 Outperform | ¥58.57B | 16.49 | 8.71% | 1.78% | 11.80% | 14.34% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |